Candel Therapeutics, Inc. (CADL)

CIK 1841387 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Candel Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 202640001873905-26-000002
Sep 10, 202640001193125-26-387924
Sep 10, 202630001193125-26-387919
Sep 10, 20261440001950047-26-009295
Sep 10, 20268-K0001193125-26-387310
Sep 9, 20268-K0001193125-26-386561
Aug 19, 202640001923794-26-000004
Aug 17, 20261440001950047-26-008263
Aug 13, 20268-K0001193125-26-347957
Aug 13, 202610-Q0001193125-26-347980
Jul 27, 2026SCHEDULE 13G0002012383-26-002278
Jul 8, 202640002139479-26-000004
Jul 8, 202630002139479-26-000003
Jul 1, 202640001909680-26-000002
Jul 1, 202640001242215-26-000018
Jul 1, 202640001923794-26-000002
Jul 1, 202640001979825-26-000006
Jul 1, 202640001494695-26-000018
Jun 29, 20261440001950047-26-006597
Jun 29, 20261440001950047-26-006607
Jun 24, 202640001867450-26-000002
Jun 24, 202640001979825-26-000004
Jun 24, 202640001494695-26-000015
Jun 24, 202640001873465-26-000002
Jun 24, 202640002013423-26-000004